Apogee Therapeutics Inc.
APGEUnited States
14 filed reports · 241 financial concepts · 0 earnings calls · 0 media appearances
Filed reports
14 reports · Jun 2023 to Jun 2026Each report counts once it has at least one extracted financial fact.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 10 | 1,218 | Jun 2023 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 3 | 857 | Dec 2023 to Dec 2025 |
| Current · 8-KSEC EDGAR | 1 | 1 | Jun 2026 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q2 | 8-K | Jun 30, 2026 | Aug 10, 2026 | 1 | Open |
| FY2026 Q2 | 10-Q | Jun 30, 2026 | Aug 10, 2026 | 271 | Open |
| FY2026 Q1 | 10-Q | Mar 31, 2026 | May 11, 2026 | 157 | Open |
| FY2025 | 10-K | Dec 31, 2025 | Mar 2, 2026 | 562 | Open |
| FY2025 Q3 | 10-Q | Sep 30, 2025 | Nov 10, 2025 | 173 | Open |
| FY2025 Q2 | 10-Q | Jun 30, 2025 | Aug 11, 2025 | 102 | Open |
| FY2025 Q1 | 10-Q | Mar 31, 2025 | May 12, 2025 | 108 | Open |
| FY2024 | 10-K | Dec 31, 2024 | Mar 3, 2025 | 135 | Open |
| FY2024 Q3 | 10-Q | Sep 30, 2024 | Nov 12, 2024 | 95 | Open |
| FY2024 Q2 | 10-Q | Jun 30, 2024 | Aug 12, 2024 | 78 | Open |
| FY2024 Q1 | 10-Q | Mar 31, 2024 | May 13, 2024 | 92 | Open |
| FY2023 | 10-K | Dec 31, 2023 | Mar 5, 2024 | 160 | Open |
Financial data
241 concepts · 2,076 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial229 concepts · 1,975 facts · Mar 2022 to Jun 2026
- Members equity22 · Mar 2022 to Jun 2026
- Cash cash equivalents restricted cash and restricted cash equivalents21 · Jun 2022 to Jun 2026
- Cash and cash equivalents at carrying value19 · Dec 2022 to Jun 2026
- General and administrative expense (US GAAP)19 · Jun 2022 to Jun 2026
- Net income loss19 · Jun 2022 to Jun 2026
- Net income loss available to common stockholders basic19 · Jun 2022 to Jun 2026
- Net income loss available to common stockholders diluted19 · Jun 2022 to Jun 2026
- Operating expenses (US GAAP)19 · Jun 2022 to Jun 2026
- Operating income loss19 · Jun 2022 to Jun 2026
- Research and development expense19 · Jun 2022 to Jun 2026
- Accounts payable current18 · Dec 2022 to Jun 2026
- Accrued external research and development expenses18 · Dec 2022 to Jun 2026
- Accrued liabilities current18 · Dec 2022 to Jun 2026
- Assets18 · Dec 2022 to Jun 2026
- Assets current18 · Dec 2022 to Jun 2026
- Common stock shares authorized18 · Dec 2022 to Jun 2026
- Comprehensive income net of tax18 · Sep 2022 to Jun 2026
- Employee related liabilities current18 · Dec 2022 to Jun 2026
- Liabilities18 · Dec 2022 to Jun 2026
- Liabilities and stockholders equity18 · Dec 2022 to Jun 2026
- Liabilities current18 · Dec 2022 to Jun 2026
- Other accrued liabilities current18 · Dec 2022 to Jun 2026
- Other assets current18 · Dec 2022 to Jun 2026
- Other nonoperating income expense18 · Sep 2022 to Jun 2026
Segment10 concepts · 93 facts · Dec 2023 to Jun 2026
- Employee benefits and share based compensation13 · Dec 2023 to Jun 2026
- General and administrative expense (US GAAP)13 · Dec 2023 to Jun 2026
- Profit loss13 · Dec 2023 to Jun 2026
- Reportable Segment13 · Dec 2023 to Jun 2026
- Depreciation12 · Mar 2024 to Jun 2026
- Income tax expense benefit12 · Mar 2024 to Jun 2026
- Interest income operating11 · Dec 2023 to Dec 2025
- Investment income interest4 · Mar 2025 to Jun 2026
- Interest expense (US GAAP)1 · Jun 2026
- Merger transaction costs1 · Jun 2026
KPI2 concepts · 8 facts · Mar 2026 to Jun 2026
- EASI-75 Response Rate7 · Mar 2026 to Jun 2026
- EASI-100 Response Rate1 · Jun 2026
Segments
93 factsFigures broken down by business line, region, product or another axis the company reports on.
Statement business segments1 member · 93 facts
- Reportable Segment Aggregation Before Other Operating93 · Dec 2023 to Jun 2026
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
- Earnings-release commentary96 claims from 7 reports · Sep 2024 to Jun 2026
- Management discussion (MD&A) commentary165 claims from 8 reports · Sep 2024 to Jun 2026
- Risk-factor changes22 claims from 1 reports · Dec 2025
- Risk factors131 risks from 2 annual reports · 2024 to 2025
Earnings calls
Transcripts with management claims and analyst questions, one per fiscal period.
No earnings-call transcripts for this company.
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.